Hogan Shea E, L'Allier Phillipe, Chetcuti Stanley, Grossman P Michael, Nallamothu Brahmajee K, Duvernoy Claire, Bates Eric, Moscucci Mauro, Gurm Hitinder S
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109-5853, USA.
Am Heart J. 2008 Sep;156(3):414-21. doi: 10.1016/j.ahj.2008.05.014.
The optimal hydration strategy for prevention of contrast-induced acute kidney injury (AKI) remains unknown. The purpose of this meta-analysis is to compare the effectiveness of normal saline (NS) versus sodium bicarbonate hydration (NaHCO(3)) for prevention of contrast-induced AKI.
We performed a meta-analysis of randomized controlled trials that compared saline-based hydration with sodium bicarbonate-based hydration regimen for prophylaxis of contrast-induced AKI. The literature search included MEDLINE, EMBASE, and Cochrane databases (2000 to October 2007); conference proceedings; and bibliographies of retrieved articles. Information was extracted on study design, sample characteristics, and interventions. Random-effects models were used to calculate summary risk ratios for contrast-induced AKI, need for hemodialysis, and death.
Seven trials with 1,307 subjects were included. Preprocedural hydration with sodium bicarbonate was associated with a significant decrease in the rate of contrast-induced AKI (5.96% in the NaHCO(3) arm versus 17.23% in the NS arm, summary risk ratio 0.37, 95% CI 0.18-0.714, P = .005). There was no difference in the rates of postprocedure hemodialysis or death. Formal testing revealed moderate heterogeneity and a strong likelihood of publication bias.
Although sodium bicarbonate hydration was found to be superior to NS in prevention of contrast-induced AKI, these results are in the context of study heterogeneity and, likely, publication bias. An adequately powered randomized controlled trial is warranted to define the optimal hydration strategy in patients at high risk of contrast-induced AKI who are scheduled to undergo contrast administration.
预防对比剂所致急性肾损伤(AKI)的最佳水化策略尚不清楚。本荟萃分析的目的是比较生理盐水(NS)与碳酸氢钠水化(NaHCO₃)预防对比剂所致AKI的有效性。
我们对随机对照试验进行了荟萃分析,这些试验比较了基于生理盐水的水化方案与基于碳酸氢钠的水化方案预防对比剂所致AKI的效果。文献检索包括MEDLINE、EMBASE和Cochrane数据库(2000年至2007年10月);会议论文集;以及检索文章的参考文献。提取了关于研究设计、样本特征和干预措施的信息。采用随机效应模型计算对比剂所致AKI、血液透析需求和死亡的汇总风险比。
纳入了7项试验,共1307名受试者。术前用碳酸氢钠水化与对比剂所致AKI发生率显著降低相关(NaHCO₃组为5.96%,NS组为17.23%,汇总风险比0.37,95%CI 0.18 - 0.714,P = 0.005)。术后血液透析或死亡率无差异。正式检验显示存在中度异质性和较强的发表偏倚可能性。
虽然发现碳酸氢钠水化在预防对比剂所致AKI方面优于NS,但这些结果是在研究异质性以及可能存在发表偏倚的背景下得出的。对于计划接受造影剂注射且发生对比剂所致AKI风险较高的患者,有必要进行一项样本量充足的随机对照试验来确定最佳水化策略。